Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Navidea Biopharmaceuticals Inc (NAVB)

0.50 -0.04 (-6.59%)

6/23/2017  4:11pm

Open:

0.55

Pre. Close:

0.54

High:

0.55

Low:

0.50

Volume:

537,332

Market Cap:

80.85M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.56 - 0.57

0.57 - 0.57

Low:

0.47 - 0.48

0.48 - 0.49

Close:

0.48 - 0.5

0.5 - 0.51

Technical analysis  (as of: 2017-06-23 4:36:50 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.64     One year: 0.72

Support:

Support1: 0.43    Support2: 0.36

Resistance:

Resistance1: 0.55    Resistance2: 0.62

Pivot:

0.52

Moving Averages:

MA(5): 0.52     MA(20): 0.50

MA(100): 0.52     MA(250): 0.62

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 46.16     %D(3): 50.31

RSI:

RSI(14): 49.09

52-Week:

High: 1.16  Low: 0.26  Change(%): -24.2

Average Vol(K):

3-Month: 943  10-Days 467

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NAVB has closed above bottom band by 32.6%. Bollinger Bands are 44.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to NAVB's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 03 Nov 2016 16:27:37 GMT
Navidea Biopharmaceuticals' (NAVB) CEO Michael Goldberg on Q3 2016 Results ...

Fri, 23 Jun 2017 19:07:30 GMT
Spark Investment Management LLC Has $284000 Stake in Navidea ...

Tue, 16 May 2017 21:00:00 GMT
BRIEF-Navidea Biopharmaceuticals says on May 12, co got a ruling in favor of ...

Thu, 01 Jun 2017 20:48:45 GMT
Annual LD Micro Invitational Investor Conference

Tue, 06 Sep 2016 12:56:33 GMT
Navidea stock jumps 76% after company agrees to $80 million Cardinal Health deal

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

161.69

Shares Float (M)

125.43

% Held by Insiders

1.14

% Held by Institutions

35.00

Shares Short (K)

13120

Shares Short Prior Month (K)

13510

Stock Financials

EPS

0.480

EPS Est. Current Year

-0.080

EPS Est. Next Year

-0.030

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

0.130

PEG Ratio

Profit Margin

347.01

Operating Margin

-7.47

Return on Assets (ttm)

-4.5

Return on Equity (ttm)

Qtrly Rev. Growth

-38.8

Gross Profit (p.s.)

0.122

Sales Per Share

EBITDA (p.s.)

-0.007

Qtrly Earnings Growth

Operating Cash Flow (M)

71.58

Levered Free Cash Flow (M)

-10.01

FoxReading.com

Valuation

P/E

1.04

P/E Growth Ratio

-0.07

P/BV

3.85

P/S

577464320.00

P/CF

1.13

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.